Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Friday, April 19, 2024

How to fight piles during lockdown

By Dr. Mahesh Chikkachannappa, Sr. Consultant - General, Laparoscopic & Bariatric Surgery, Aster CMI Hospital Piles, which is a serious health problem, and has many...

REMEDI Introduces Best-in-Class, Affordable & Innovative Handheld X-Ray Solution to India

New Delhi, September  19, 2023:  Remedi, a leading Korean research & radiology device company with cutting-edge products known for its expertise in radiology solutions,...

Biotechnology

DEP’s innovative solution MeshWorks 2020 is set to revolutionize the Bio-Medical Industry

MeshWorks 2020 will make product development in the healthcare industry more efficient and productive Chennai, May 14, 2020: DEP MeshWorks 2020, a CAE driven engineering platform, for...

Surge in Avascular Necrosis of the Femoral Head in India Post-COVID: A Closer Look...

New Delhi, August 21, 2023: The COVID-19 pandemic has cast an unprecedented shadow over the world, disrupting lives and healthcare systems in ways we never...

IT & Software Support

Appointments

Awards

Financial Results

Hester Biosciences Limited Q4 and FY22 Results

- FY22 Standalone revenues up 5%, Consolidated revenues up 10% - FY22 Standalone PAT down 1%,...

Morepen Labs’ Net Profit Rises by 153 Per cent Led by Strong API Business in Q1’FY 2020-21

New Delhi, August 31, 2020: Highlights: Q1’fy 2020-21 (Consolidated) Performance at a Glance (Rs. in Crores) Particulars Q1’FY 2020-21 Q1’FY...

Approvals

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Dr. Agarwal’s Eye Hospital Organises Walkathon on Eye Donation in Bengaluru

Bengaluru , September 7, 2022: Dr. Agarwal's Eye Hospital organized a Walkathon in Bengaluru to raise awareness about eye donation as part of the ongoing National...

Unlocking Vision Wellness: Allergan’s Media Conclave on World Sight Day Spotlights Eyecare’s Crucial Role...

New Delhi, October 12, 2023 :  This World Sight Day, Allergan, an AbbVie company, came together with renowned experts in the field of ophthalmology...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

74th Independence Day Celebrated With Fervor at KIMS – ICON Hospital

Visakhapatnam, August 15, 2020: The 74th Independence Day was celebrated in all its solemnity and grandeur at KIMS-ICON Hospital, Sheela Nagar Vizag. The Celebration of...

India Needs Stringent Regulation & Certification-Mechanism to Ensure Authenticity of Personal Hygiene Products: Opine...

Need to scan whether the new age personal care proclaimed natural products are natural: Say mothers New Delhi, September 25, 2020: An oft-repeated maxim — 'Cleanliness...

Indoor Air Quality for High-Performance Workspaces!

Is the Air Quality at your workspace a business enabler or is it detrimental to health? See how IAQ at workspaces transform the productivity...

Dental Care

Hospital Management

Drug Discovery & Development

Suppliers

Technology

Companies

Marketing

Our Partners

Machinery & Equipments